Cardiovascular Diseases Clinical Trial
Official title:
Effects of Exercise Training on Cardiovascular Health in Middle-aged Women
NCT number | NCT02135575 |
Other study ID # | CWS-WP2CV |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2014 |
Est. completion date | July 2017 |
Verified date | August 2018 |
Source | University of Copenhagen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The hypothesis of the present study is that physical training can oppose detrimental changes in cardiovascular and metabolic health associated with estrogen loss after menopause.
Status | Completed |
Enrollment | 36 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 45 Years to 57 Years |
Eligibility |
Inclusion Criteria: - Premenopausal (45-53 years) OR postmenopausal 50-57 years - BMI> 18.5 and <30 - Sedentary (no regular physical activity the last 2 years) - Plasma measurements - Premenopausal: estradiol> 0.20 nmol/l, Follicle stimulating hormone < 22 IU/l and progesterone >2.5 nmol/l - Postmenopausal: estradiol < 0.20 nmol/l, Follicle stimulating hormone > 22 IU/l and progesterone 0.3-2.5 nmol/l Exclusion Criteria: - Smoking - Excessive alcohol intake - Regular medication including hormone replacement treatment - Chronic disease |
Country | Name | City | State |
---|---|---|---|
Denmark | University of Copenhagen | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
University of Copenhagen | Glostrup University Hospital, Copenhagen, Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Anthropometry | Dual x-ray absorptiometry, height, weight, waist and hip circumference | Baseline comparison and changes from baseline to 3 months | |
Other | Activity measure | Activity measure for one week by accelerometer | Baseline comparison and changes from baseline to 3 months | |
Primary | Leg vascular function | Measurements of leg blood flow by ultrasound doppler during exercise and during femoral arterial infusion of vasodilators | Baseline comparison and changes from baseline to 3 months | |
Primary | Cardiac structure and function | Magnetic resonance imaging and transthoracic echocardiography | Baseline comparison and changes from baseline to 3 months | |
Primary | Platelet function | Platelet aggregation assay of whole blood and platelet rich plasma | Baseline comparison and changes from baseline to 3 months | |
Secondary | Expression of proteins in muscle samples | Western Blot analysis of proteins of relevance for vascular function and metabolism | Baseline comparison and changes from baseline to 3 months | |
Secondary | Maximal aerobic effect | Maximal oxygen uptake during an incremental cycle ergometry test with gas analysis | Baseline comparison and changes from baseline to 3 months | |
Secondary | Genomic profile in blood samples | Genomic analysis of parameters for vascular and metabolic health | Baseline comparison and changes from baseline to 3 months | |
Secondary | Insulin sensitivity and glycaemic control | Fasting plasma glucose analysis and oral glucose tolerance test | Baseline comparison and changes from baseline to 3 months | |
Secondary | Arterial blood pressure | Baseline comparison and changes from baseline to 3 months | ||
Secondary | Gene expression of proteins in muscle samples | Gene analysis of relevance for vascular and metabolic function | Baseline comparison and changes from baseline to 3 months | |
Secondary | Health related parameters in blood | Plasma lipid status and other variables related to vascular health | Baseline comparison and changes from baseline to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|